Please use this identifier to cite or link to this item:
|Title:||Medication use and retinal vessel diameters|
|Authors:||Wong, T.Y. |
|Citation:||Wong, T.Y., Knudtson, M.D., Klein, B.E.K., Klein, R., Hubbard, L.D. (2005). Medication use and retinal vessel diameters. American Journal of Ophthalmology 139 (2) : 373-375. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ajo.2004.08.008|
|Abstract:||Purpose: To study the influence of different medications on retinal vessel diameters. Design: Cross-sectional study. Methods: Retinal photographs in the Beaver Dam Eye Study (n = 4926, aged 43 to 84 years) were digitized, and the diameters of retinal vessels were measured. Participants' current medications were recorded at the examination. Results: There were few significant associations between medication use and retinal vessel diameters. After adjusting for age, blood pressure, and other factors, participants who were using topical beta-blocker eyedrops had narrower retinal arteriolar (P = .05) and venular (P = .006) diameters than nonusers. Systemic beta-blocker was not associated with retinal vessel diameter size. Conclusion: We found few associations between current medication use and retinal vessel diameter. Retinal vessels were narrowed in those taking antiglaucoma medications, most strikingly in those prescribed topical beta-blockers, although such a relationship could not be established among those using systemic beta-blockers. © 2005 by Elsevier Inc. All rights reserved.|
|Source Title:||American Journal of Ophthalmology|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on May 21, 2018
WEB OF SCIENCETM
checked on Apr 24, 2018
checked on Feb 25, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.